KAWANAMI Haruka

FacultyHealth Evaluation Center
PositionAssistant Professor

Researcher Profile & Settings

Degree

  • Ph.D in Medicine

Research Activities

Published Papers

  • Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD, Takuji Nakamura, Tomomi Satoh-Nakamura, Akio Nakajima, Takafumi Kawanami, Tomoyuki Sakai, Yoshimasa Fujita, Haruka Iwao, Miyuki Miki, Yasufumi Masaki, Toshiro Okazaki, Yasuhito Ishigaki, Mitsuhiro Kawano, Kazunori Yamada, Shoko Matsui, Takako Saeki, Terumi Kamisawa, Motohisa Yamamoto, Hideaki Hamano, Tomoki Origuchi, Shintaro Hirata, Yoshiya Tanaka, Hiroto Tsuboi, Takayuki Sumida, Kazuichi Okazaki, Masao Tanaka, Tsutomu Chiba, Tsuneo Mimori, Hisanori Umehara, Modern Rheumatology30:551-557May 2020
  • Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease, Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, Nozomu Kurose, Sohsuke Yamada, Mariko Doai, Munetaka Matoba, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Hiroki Mizumaki, Masaki Yamaguchi, Yasufumi Masaki, Internal Medicine58:2555-2560Sep. 2019
  • Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?, Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, Nozomu Kurose, Sohsuke Yamada, Kazue Takai, Sadao Aoki, Junya Kuroda, Makoto Ide, Keigo Setoguchi, Norifumi Tsukamoto, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, American Journal of Hematology94:975-983Sep. 2019
  • The treatment strategy of IgG4-related disease - from the result of prospective clinical study -, Yasufumi.Masaki, Shino.Fujimoto, Haruka.Kawanami (Iwao), Tomoyuki.Sakai, Takafumi.Kawanami, Yopshimasa.Fujita, Hiroshi.Kawabata, Toshihiro.Fukushima29:140-146Jun. 2017
  • A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease, Yasufumi.Masaki, shoko.Matsui, Takako.Saeki, Hiroto.Tsuboi, Shintaro.Hirata, Yasumori.Izumi, Taiichiro.Miyashita, Keita.Fujikawa, Hiroaki.Dobashi, Kentaro.Susaki, Hisanori.Morimoto, Kasutaka.Takagi, Mitsuhiro.Kawano,Tomoki.Origuchi, Yoko.Wada, Naoki.Takahashi, Masanobu.Horikashi, Hiroshi.Ogishima, Yasunori.Suzuki, Takafumi.Kawanami, Haruka.Kawanami Iwao, Tomoyuki.Sakai, Yoshimasa.Fujita, Toshihiro.Fukushima, Masatoshi.Saito, Ritsuro.Suzuki, Yuko.Morikawa, Tadashi.Yoshino, Shigeo.Nakamura, Masaru.Kojima, Nozomu.Kurose, Yasuharu.Sato, Yoshiya.Tanaka, Susumu.Sugai, Takayuki.Sumida, Modern Rheumatology27:849-854May 2017
  • How to diagnose and treat IgG4-related disease, Y.Masaki, S.Fujimoto, H.Kawanami(Iwao), T.Sakai, T.Kawanami, Y.Fujita, H.Kawabata, T.Fukushima, Journal of Kanazawa Medical University41:67-72Dec. 2016
  • Isolation of vascular smooth muscle antigen-reactive CD4(+)αβTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas(+/+) mice., Y.Fujita, T.Fujii, H.Shimizu, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, M.Tanaka, Y.Masaki, T.Fukushima, T.Okazaki, H.Umehara, T.Mimori, Cellular immunology303:50-542016
  • Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version., Y.Masaki, H.Kawabata, K.Takai, M.Kojima, N.Tsukamoto, Y.Ishigaki , N.Kurose, M.Ide, J.Murakami, K.Nara, H.Yamamoto, Y.Ozawa, H.Takahashi, K.Miura, T.Miyauchi, S.Yoshida, A.Momoi, N.Awano, S.Ikushima, Y.Ohta, N.Furuta, S.Fujimoto, H.Kawanami, T.Sakai, T.Kawanami, Y.Fujita, T.Fukushima, S.Nakamura, T.Kinoshita, S.Aoki, International journal of hematology103:686-6922016
  • Diagnosis and treatment of IgG4-related disease-Including IgG4-related skin disease-, Y.Masaki, H.Shimizu, T.Nakamura(Satoh), T.Nakamura, A.Nakajima, H.Kawanami(Iwao), T.Kawanami, K.Yamada, Y.Hamaguchi, M.Kawano, Y.Fujita, T.Fukushima, Journal of Environmental Dermatology and Cutaneous Allergology9:212-217Oct. 2015
  • Decreased expression of innate immunity-related genes in peripheral blood mononuclear cells from patients with IgG4-related disease, A.Nakajima, Y.Masaki, T.Nakamura, T.Kanawami, Y.Ishigaki, T.Takegami, M.Kawano, K.Yamada, N.Tsukamoto, S.Matsui, T.Saeki, K.Okazaki, T.Kamisawa, T.Miyashita, Y.Yakushijin, K.Fujikawa, M.Yamamoto, H.Hamano, T.Origuchi, S.Hirata, H.Tsuboi, T.Sumida, H.Morimoto, T.Sato, H.Iwao, M.Miki, T.Sakai, Y.Fujita, M.Tanaka, T.Fukushima, T.Okazaki, H.Umehara, PLoS One10:e0126582-e0126582May 2015
  • CD14+ follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related disease, T.Satoh-Nakamura, N.Kurose, T.Kawanami, T.Nakamura, H.Iwao-Kawanami, A.Nakajima, M.Miki, T.Sakai, Y.Fujita, M.Tanaka, T.Fukushima, Y.Masaki, Biomedical Research36:143-153Feb. 2015
  • Thymic lymphoid hyperplasia with multilocular thymic cysts diagnosed before the Sjögren syndrome diagnosis, H.Minato, E.Kinoshita, S.Nakada, T.Nojima, M.Tanaka, K.Usuda, M.Sagawa, H.Iwao, M.Tanaka, M.Doai, T.Takahashi, N.Shibata, Diagnostic Pathology10:103-1082015
  • Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group, T.Sakai, Y.Masaki, N.Otsuki, I.Sakamaki, S.Kishi, T.Miyazono, Y.Urasaki, J.Murakami, T.Satoh, T.Nakamura, H.Iwao, A.Nakajima, T.Kawanami, M.Miki, Y.Fujita, M.Tanaka, T.Fukushima, T.Okazaki, T.Ueda, Medical Oncology32:232-2382015
  • IgG4-related disease:Diagnostic methods and therapeutic strategies in Japan, Y.Masaki, H.Shimizu, T.Sato, T.Nakamura, A.Nakajima, H.Iwao, M.Miki, T.Sakai, T.Kawanami, Y.Fujita, M.Tanaka, T.Fukushima, Journal of clinical and experimental hematopathology : JCEH.54:95-1012014
  • Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Faslpr mice, Y.Fujita, T.Fujii, T.Mimori, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, M.Tanaka, Y.Masaki, T.Fukushima, T.Okazaki, H.Umehara, Journal of immunology (Baltimore, Md. : 1950)192:979-9842014
  • Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Faslpr mice, Y.Fujita, T.Fujii, T.Mimori, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, M.Tanaka, Y.Masaki, T.Fukushima, T.Okazaki, H.Umehara, Journal of immunology (Baltimore, Md. : 1950)192:979-9842014
  • Japanese variant of multicentirc cattleman's disease associated with serositis and thrombocytopenia-a report of two cases: Is TAFRO syndrome(Castleman-Kojima Disease) a distinct clinicopathological entity?, Y.Masaki, A.Nakajima, H.Iwao, N.Kurose, T.Sato, T.Nakamura, M.Miki, T.Sakai, T.Kawanami, T.Sawaki, Y.Fujita, M.Tanaka, T.Fukushima, T.Okazaki, H.Umehara, Journal of clinical and experimental hematopathology : JCEH.53:79-85Jun. 2013
  • Daily 500mg valacyclovir is effective for prevention of varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib, T.Fukushima, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, T.Okazaki, H.Nakajima, Y.Motoo, H.Umehara, Anticancer research.32:5437-54402012
  • Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease, Y.Masaki, N.Kurose, M.Yamamoto, H.Takahashi, T.Saeki, A.Azumi, S.Nakada, S.Matsui, T.Origuchi, S.Nishiyama, K.Yamada, M.Kawano, A.Hirabayashi, K.Fujikawa, T.Sugiura, M.Horikoshi, N.Umeda, H.Minato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.sawaki, T.Kawanami, Y.Fujita, M.Tanaka, T.Fukushima, K.Eguchi, S.Sugai, H.Umehara, International journal of rheumatologye580814,1-52012
  • Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events, T.Fukushima, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sato, T.Sakai, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, H.Nakajima, Y.Motoo, H.Umehara, Anticancer research.31:2297-2302Sep. 2011
  • IgG4-related Mikulicz's disease and Sjogren's syndrome, Y.Masaki, T.Nakamura, H.Iwao, A.Nakajima, H.Umehara55:763-769Aug. 2011
  • Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia, T.Fukushima, H.Kawabata, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, Y.Hirose, H.Umehara, Anticancer research.31:1741-1744May 2011
  • A case of Castleman disease with status epileptics originating from focal cortical dysplasia, M.Kaito, H.Iwao, E.Kinoshita, H.Funaki, O.Tachibana, M.Matsui51:487-4922011
  • Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma, T.Fukushima, T.Nakamura, H.Iwao, H.Umehara, American journal of hematology.86:8932011
  • IgG4-related disease (IgG4+MOLPS)-diagnostic criteria and diagnostic problems, Y.Masaki, H.Iwao, A.Nakajima, M.Miki, S.Sugai, H.Umehara, Current immunology reviews7:172-1772011
  • High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma, Y.Masaki, M.Miki, Y.Sun, T.Nakamura, H.Iwao, A.Nakajima, N.Kurose, T.Sakai, Z.Jin, T.Sawaki, T.Kawanami, Y.Fujita, M.Tanaka, T.Fukushima, Y.Hirose, H.Umehara, International journal of hematology.93:720-7262011
  • Proteomics analysis in IgG4-related disease, H.Iwao35:131-139Oct. 2010
  • Comprehensive analysis of protein-expression changes specific to immunoglobulin G4-related disease, Takafumi Kawanami, Haruka Kawanami-Iwao, Takanobu Takata, Yasuhito Ishigaki, Naohisa Tomosugi, Tsutomu Takegami, Hiroto Yanagisawa, Shino Fujimoto, Tomoyuki Sakai, Yoshimasa Fujita, Kazunori Yamada, Shuichi Mizuta, Hiroshi Kawabata, Toshihiro Fukushima, Yuko Hirose, Yasufumi Masaki, Clinica Chimica Acta523:45-572021
  • Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion, Hiroto Yanagisawa, Shuichi Mizuta, Hiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, Haruka Iwao-Kawanami, Takafumi Kawanami, Kazunori Yamada, Toshihiro Fukushima, Katsunori Kyoda, Yasufumi Masaki, Annals of Hematology100:2121-2123Aug. 2021
  • Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes, Hiroto Yanagisawa, Hiroshi Kawabata, Yusuke Ueda, Kotaro Arita, Haruka Iwao-Kawanami, Tomoyuki Sakai, Takafumi Kawanami, Kazunori Yamada, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, International Journal of Hematology116:81-882022